Complications of botulinum toxin A use in facial rejuvenation

Facial Plastic Surgery Clinics of North America

Volumn 13, Issue 1, 2005, Pages 1-10

  Vartanian, A John ^a   Dayan, Steven H ^b  

^a Lasky Clinic   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA TOCOPHEROL; AMINOGLYCOSIDE; AMINOQUINOLINE DERIVATIVE; APRACLONIDINE; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CHLOROQUINE; CYCLOSPORIN; ELA MAX; EMLA; GARLIC EXTRACT; GENTAMICIN; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HYDROXYCHLOROQUINE; LINCOSAMIDE; LUBRICATING AGENT; MAGNESIUM SULFATE; MUSCLE RELAXANT AGENT; MYFRIN; NAPHAZOLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PHENYLEPHRINE; QUINIDINE; SUXAMETHONIUM; WARFARIN;

BLEPHAROSPASM; CLINICAL TRIAL; DIPLOPIA; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; DRY EYE; DRY SKIN; DYSPHAGIA; DYSTONIA; ECCHYMOSIS; ECTROPION; EDEMA; ESTHETICS; FACE SURGERY; FACIAL EXPRESSION; FLU LIKE SYNDROME; HEADACHE; HOARSENESS; HUMAN; HYPESTHESIA; INJECTION SITE; LAGOPHTHALMOS; LIP DISEASE; MALAISE; MUSCLE WEAKNESS; NECK MUSCLE; NEUROMUSCULAR DISEASE; NONHUMAN; ORBIT DISEASE; PAIN; PATIENT SATISFACTION; PSORIASIS; PTOSIS; RESPIRATORY FAILURE; REVIEW; RHYTIDOPLASTY; SKIN BRUISING; SKIN INFECTION; SKIN MANIFESTATION; STRABISMUS; UPPER LIP; XEROSTOMIA;

BOTULINUM TOXIN TYPE A; FACE; HUMANS; NEUROMUSCULAR AGENTS; REJUVENATION; SKIN AGING;

EID: 9244255362     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2004.04.008     Document Type: Review

References (65)

1. Lowe N.J. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives Dermatol Surg 24 11 1998 1216-1218
2. Blitzer A. Binder W.J. Boyd J.B. et al. Management of facial lines and wrinkles 2000 Lippincott Williams & Wilkins Philadelphia
3. Comella C.L. Cervical dystonia: Treatment with botulinum toxin serotype A as Botox or Dysport In: Brin M.F. Jankovic J. Hallett M. editors Scientific and therapeutic aspects of botulinum toxin 2002 359-364 Lippincott Williams & Williams Philadelphia
4. Kwak C.H. Hanna P.A. Jankovic J. Botulinum toxin in the treatment of tics Arch Neurol 57 8 2000 1190-1193
5. Aoki K.R. Pharmacology and immunology of botulinum toxin serotypes J Neurol 248 Suppl 1 2001 3-10
6. Product Information Package Insert. (71390US12J) 2002 Allergan Inc. Irvine, California
7. Carruthers J.D.A. Carruthers J.A. Botulinum toxin in clinical ophthalmology Can J Ophthalmol 131 1996 389-400
8. Matarasso S.L. Complications of botulinum A exotoxin for hyperfunctional lines Dermatol Surg 24 11 1998 1249-1254
9. Carruthers J.A. Lowe N.J. Menter M.A. et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines J Am Acad Dermatol 46 6 2002 840-849
10. Blitzer A. Binder W.J. Aviv J.E. Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles Facial Plast Surg Clin N Am 9 3 2001 395-404
11. Physicians Desk Reference 56th edition 2002 Thompson Medical Economics Montvale (NJ)
12. Mosby's Drug Consult 13th edition 2003 Mosby St. Louis (MO)
13. Hatheway C.G. Immunology of botulinum toxin 1993 Marcel-Dekker New York
14. Arnon S.S. Clinical botulism In: Brin M.F. Jankovic J. Hallett M. editors Scientific and therapeutic aspects of botulinum toxin 2002 145-150 Lippincott Williams & Williams Philadelphia
15. Brin M.F. Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology Muscle Nerve Suppl 6 1997 S208-S220
16. Lu L. Atchabahian A. Mackinnon S. et al. Nerve injection injury with botulinum toxin Plast Reconstr Surg 101 1998 1875-1880
17. Wang Y.C. Burr D.H. Korthals G.J. et al. Acute toxicity of aminoglycosides antibiotics as an aid to detecting botulism Appl Environ Microbiol 48 1984 951-955
18. Kadieva V.S. Friedman L. Margolius L.P. et al. Neuromuscular blockade and ventilatory failure after cyclosporine Can J Anesth 39 1992 402-403
19. Bucknall R.C. Myasthenia associated with d-penicillamine therapy in rheumatoid arthritis Proc R Soc Med 70 Suppl 3 1977 114-117
20. Albers J.W. Hodach R.J. Kimmel D.W. et al. Penicillamine-associated myasthenia gravis Neurology 30 1980 1246-1249
21. Simpson L.L. The interaction between aminoquinolones and presynaptically acting neurotoxins J Phamacol Exp Ther 222 1982 43-48
22. Lange D.J. Rubin M. Greene P.E. et al. Distant effects of locally injected botulinum toxin: A double-blind study of single fiber EMG changes Muscle Nerve 14 1991 672-675
23. Atassi M.Z. Oshima M. Strucutre, activity, and immune (T and B cell) recognition of botulinum neurotoxins Crit Rev Immunol 19 1999 219-260
24. Dressler D. Dirnberger G. Bhatia L. et al. Botulinum toxin aniotbody testing: Comparisson between an immunopercipitation assay and the mouse diaphragm assay Eur Neurol 45 2001 257-260
25. Jankovic J. Botulinum toxin in movement disorders Curr Opin Neurol 7 1994 358-366
26. Naumann M. Toyka K.V. Mansour T.B. et al. Depletion of neutralizing antibodies resensitises non-responder to botulinum A neurotoxin J Neurol Neurosurg Psychiatry 65 1998 924-927
27. Greene P. Fahn S. Diamond B. Development of resistance to botulinum toxin A in patients with torticollis Movement Disorder 9 1994 213-217
28. Hatheway C.L. Dang C. Immunogenecity of the neurotoxins of Clostriduim botulinum In: Jankovic J. Hallett M. editors Therapy with Botulinum toxin 1994 93-107 Dekker New York
29. Goschel H. Wohlfarth K. Frevert J. et al. Botulinum toxin therapy, Neutralizing and non-neutralizing antibodies Exp Neurol 147 1 1997 96-102
30. Matarasso A. Deva K. et al. American Society of Plastic Surgeons DATA Committee Botulinum yoxin Plast Reconstr Surg 109 3 2002 1191-1197
31. Jankovic J. Botulinum toxin: Clinical implications of antigeniticity and immunoresistance In: Brin M.F. Jankovic J. Hallet M. editors Scientific and therapeutic aspects of botulinum toxin 2002 409-415 Lippincott Williams & Williams Philadelphia
32. Ramirez A.L. Reeck J. Maas C.S. Botulinum toxin type B (Myobloc) in the management of hyperkinetic facial lines Otolaryngol Head Neck Surg 126 2002 459-467
33. Sadick N.S. Botulinum toxin type B (myoblock) for glabellar wrinkles: a prospective open-label response study Dermatol Surg 29 2002 817-821
34. Huang W. Foster J.A. Rogachefsky A.S. Pharmacology of botulinum toxin J Am Acad Dermatol 43 2 2000 249-259
35. Scott A.B. Clostridial toxins as therapeutic agents In: Simpson L. editor Botulinum neurotoxin and tentanus toxin 1989 399-406 Academic Press New York
36. Jankovic N. Brin M.F. Therapeutic uses of botulinum toxin N Engl J Med 324 17 1991 1186-1193
37. Kessler K.R. Skutta M. Benecke R. Long-term treatment of cervical dystonia with BTX-A: Efficacy, safety, and antibody frequency. German Dystonia Study Group J Neurol 246 1999 265-274
38. Lowe N.J. Lask G. Yamauchi P. et al. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patient with crow's feet J Am Acad Dermatol 47 6 2002 834-840
39. Matarasso A. Matarasso S.L. Brandt F.S. et al. Botulinum toxin for the management of platysmal bands Plast Reconstr Surg 103 2 1999 645-652
40. Carruthers A. Carruthers J. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin Dermatol Surg 24 11 1998 1189-1194
41. Alam M. Dover J.S. Arndt K.A. Pain associated with injection of botulinum toxin A exotoxin reconstituted using isotonic sodium chloride with and without preservative Arch Deramtol 138 2002 510-514
42. Aoki K.R. Pharmacology and immunology of botulinum toxin serotypes J Neurol 248 Suppl 1 2001 3-10
43. Bowden J.B. Rapini R.P. Psoriasiform eruption from intramuscular botulinum A toxin Cutis 50 1992 415-416
44. Bulstrode N.W. Grobelaar A.O. Long-term prospective follow-up of botulinum toxin treatment for facial rhytids Aesthetic Plast Surg 26 2002 356-359
45. Brin M.F. Binder W. Blitzer A. et al. Botulinum toxin type A botox for pain and headache In: Brin M.F. Jankovic J. Hallett M. editors Scientific and therapeutic aspects of botulinum toxin 2002 233-250 Lippincott Williams & Williams Philadelphia
46. Werschler P. Baumann L. Everything you need to know about Botox injections Skin Aging 9 2001 36-42
47. Wilson F. Botulinum toxin-A risks overcome by proper technique Cosmetic Surgery Times 2001 12-15
48. Alam M. Severe, intractable headache after injection with botulinum a exotoxin: Report of 5 cases J Am Acad Dermatol 46 1 2002 62-65
49. Borodic G.E. Ferrante R.J. Pearce L.B. et al. Pharmacology and histology of the therapeutic application of botulinum toxin In: Jankovic J. Hallett M. editrors Therapy with botulinum toxin 1994 119-158 Marcel Dekker New York
50. Garcia A. Fulton J.E. Cosmetic denervation of the muscles of facial expression with botulinum toxin Dermatol Surg 22 1996 39-43
51. Ramirez O.M. Spastic frontalis: Eyelid laxity syndrome. Presented at the Annual Meeting of the American Society of Aesthetic Plastic Surgery. San Francisco, March 19-24, 1995
52. Carruthers A. Carruthers J.A. Cosmetic uses of botulinum A exotoxin In: Kelin A.W. editor Tissue augmentation in clinical practice 1998 207-236 Marcel Dekker New York
53. Keen M. Blitzer A. Aviv J. et al. Botulinum toxin A for hyperkinetic facial lines: Results of a double blind, vehicle-controlled study Plast Reconstruct Surgery 94 1994 94-99
54. Lowe H.J. Maxwell A. Harper H. Botulinum A exotoxin for glabellar folds: A double-blind, vehicle controlled study with an electromyographic injection techniqu J Am Acad Dermatol 35 1996 569-572
55. Scott A.B. Botulism toxin injection of extra ocular muscles as an alternative to strabismus surgery Trans Ophthalmol Soc 87 1981 1044-1049
56. Binder W.J. Blitzer A. Brin M.F. Treatment of hyperfunctional lines of the face with botulinum toxin A Dermatol Surg 24 11 1998 1198-1205
57. Carruthers J.D.A. Carruthers A. Botulinum toxin and laser resurfacing for lines around the eyes In: Blitzer W.J. Binder W.J. Boyd J.B. Carruthers A. editors Management of facial lines and wrinkles 2000 315-332 Lippincott Williams & Wilkins Philadelphia
58. Paloma V. Samper A. A complication with aesthetic use of Botox: herniation of the orbital fat Plast Reconstr Surg 107 5 2001 1315-1316
59. Matarasso S.L. Matarasso A. Treatment guidelines for botulinum toxin type A for the periocular region and partial upper lip ptosis following injections to the lateral canthal rhytids Plast Reconstr Surg 108 1 2001 208-214
60. Brandt F.S. Bellman B. Cosmetic use of botulinum A exotoxin for the aging neck Derm Surgery 24 1998 232-234
61. Comella C.L. Tanner C.M. Defoor L. et al. Dysphagia following botox injections for spasmodic torticollis Neurology 42 1992 1307-1310
62. Kane M.A.C. Nonsurgical treatment of platysmal bands with injection of botulinum toxin A Plast Reconstr Surg 103 2 1999 656-663
63. Matarasso A. Terino E.O. Forehead brow rhytidoplasty: Reassessing the goals Plast Reconstruct Surg 93 7 1994 1378-1389
64. Huang W. Rogachefsky A.S. Foster J.A. Brow lift with botulinum toxin Dermatolog Surg 26 2000 55-60
65. Frankel A.S. Kamer F.M. Chemical browlift Arch Otolaryngol Head Neck Surg 124 3 1998 321-333